|
AI-driven solutions poised to revolutionize compliance and data integrity practices: Expert
|
|
Shardul Nautiyal, Mumbai
April 15 , 2024
|
|
|
In a ground-breaking development for the pharmaceutical industry, Nilay Sharma, the director of Proteus Technologies has unveiled innovative AI-driven solutions poised to revolutionize compliance and data integrity practices. Leveraging cutting-edge technology, these advancements promise to streamline processes, mitigate risks, and uphold regulatory standards with unprecedented efficiency.
The integration of artificial intelligence (AI) and enterprise resource planning (ERP) systems marks a significant milestone in the quest for enhanced compliance within pharmaceutical manufacturing. With regulatory inspections often uncovering lapses in adherence to established procedures, the need for comprehensive solutions has never been more pressing.
Through the deployment of AI-powered tools like Vision AI, Proteus Technologies empowers pharmaceutical companies to bridge the gap between SOPs and operational execution seamlessly. By providing real-time, contextualized guidance and citations from SOPs, Vision AI serves as a reliable resource for employees, bolstering their understanding and decision-making capabilities.
The unveiling of these AI-driven solutions represents a paradigm shift in pharmaceutical compliance, ushering in a new era of efficiency, transparency, and accountability. As the industry embraces digital transformation, Proteus Technologies stands at the forefront, pioneering innovative solutions that promise to reshape the landscape of pharmaceutical manufacturing for years to come.
Sharma further underscored the pivotal role of AI and ERP integration in bolstering compliance and data integrity within the pharmaceutical industry.
Sharma emphasized the critical need for pharmaceutical companies to adhere to established procedures and regulatory standards, citing frequent instances of non-compliance stemming from a knowledge gap among employees. He stressed the importance of aligning with cGMP and GLP principles, emphasizing the mantra of "saying what you do and doing what you say" to ensure successful regulatory inspections and audits.
Highlighting the transformative potential of Vision AI, Sharma revealed how Proteus Technologies' customers have leveraged the platform to streamline compliance efforts. Vision AI processes Standard Operating Procedures (SOPs) and provides responses in plain English, empowering employees to better understand processes and make informed decisions. Sharma noted that Vision AI serves as a reliable resource, bridging the gap between employees' knowledge and the intricacies of SOPs.
Moreover, Sharma discussed the significance of AI in improving data integrity within pharmaceutical manufacturing. Proteus Technologies' AI engine enables the conversion of unstructured data into structured formats with near-perfect accuracy, facilitating the digitization of documentation and instrument outputs. This integration with ERP systems ensures comprehensive data storage and audit readiness, addressing regulatory requirements effectively.
Sharma further elaborated on the role of ERPs in enhancing data integrity practices. These systems offer streamlined data capture, robust access control, and real-time data visibility, empowering manufacturers to maintain compliance and uphold patient safety standards. By embracing Pharma 4.0 principles, ERPs facilitate predictive maintenance and optimization of manufacturing processes, driving efficiency and quality improvements.
Sharma emphasized the importance of a holistic approach to data integrity, combining technological advancements with cultural shifts within organizations. He underscored the significance of employee training, leadership commitment, and continuous improvement initiatives in fostering a culture of accountability and ethical behaviour.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|